Autoinflammatory Disease Genetics and Clinical Phenotypes

Autoinflammatory diseases are characterised by dysregulated innate immune responses that lead to unprovoked systemic inflammation without high-titre autoantibodies or antigen-specific T cells. Many represent monogenic disorders caused by mutations in genes encoding pattern recognition receptors, cytokine regulators and inflammasome components. Advances in high-throughput sequencing have revealed not only single-gene defects but also oligogenic and digenic inheritance patterns, underscoring the influence of genetic background and environmental triggers on disease expression. Clinical phenotypes range from periodic fever syndromes and urticarial rash to granulomatous arthritis, uveitis and skin manifestations, often overlapping in mixed presentations that challenge traditional diagnostic categories. Integrative phenotype-genotype correlation frameworks now incorporate molecular diagnostics, transcriptomics and proteomics to refine patient stratification and guide targeted treatment. Recent work has elucidated key inflammatory pathways—from NLRP3 and pyrin inflammasome activation to NOD2-mediated T cell regulation—paving the way for precision therapies such as cytokine inhibitors and small-molecule modulators. These developments carry global significance by improving diagnostic accuracy, informing genetic counselling and opening new avenues for personalised management of autoinflammatory disorders.

Research from Nature Portfolio

Recent studies have redefined the role of NOD2 beyond innate sensing, demonstrating a T cell-intrinsic function that restrains Th17-mediated uveitis. Experiments comparing receptor-deficient and receptor-competent CD4+ T cells in lymphopenic hosts revealed that NOD2 operates downstream of T cell receptor engagement to suppress memory cell activation and interleukin-17 production. T cells from patients with Blau syndrome mirrored this phenotype, exhibiting heightened Th17 responses in the absence of functional NOD2. These findings identify NOD2 as a rheostat within adaptive immunity and suggest novel T cell-targeted approaches for NOD2-associated granulomatous diseases.

Autoinflammatory Disease Genetics and Clinical Phenotypes publication trend

The graph below shows the total number of articles in autoinflammatory disease genetics and clinical phenotypes across all publications each year (not limited to Nature Index journals).

Technical terms

Autoinflammatory disease: innate immune disorders marked by unprovoked systemic inflammation without high-titre autoantibodies or antigen-specific T cells.

NOD-like receptors (NLRs): intracellular sensors that detect microbial or damage-associated signals to initiate inflammatory responses.

NOD2: a member of the NLR family that recognises muramyl dipeptide and regulates NF-κB, MAPK and adaptive T cell pathways.

Phenotype-genotype correlation: analysis linking specific genetic variants to observed clinical features.

Granuloma: structured aggregate of immune cells, chiefly macrophages and lymphocytes, formed in chronic inflammation.

Th17 cells: subset of CD4+ T lymphocytes producing interleukin-17, central to mucosal immunity and inflammatory pathology.

Biomarker: measurable biological molecule indicating disease presence, activity or response to therapy.

References

1. T cell-intrinsic role for Nod2 in protection against Th17-mediated uveitis. Nature Communications (2020).
2. Implications of combined NOD2 and other gene mutations in autoinflammatory diseases. Frontiers in Immunology (2023).
3. Proteomic Profiling of Tears in Blau Syndrome Patients in Identification of Potential Disease Biomarkers. International Journal of Molecular Sciences (2024).
4. Identifying functional dysregulation of NOD2 variant Q902K in patients with Yao syndrome. Arthritis Research & Therapy (2024).